Anja Mueller Selected Research

Member 2 Subfamily B ATP Binding Cassette Transporter

8/2020	Identification of microRNAs Targeting the Transporter Associated with Antigen Processing TAP1 in Melanoma.
1/2020	Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anja Mueller Research Topics

Disease

16	Neoplasms (Cancer) 12/2023 - 10/2004
7	Melanoma (Melanoma, Malignant) 01/2024 - 01/2017
2	Neoplasm Metastasis (Metastasis) 01/2024 - 12/2023
1	Human Influenza (Influenza) 11/2022
1	COVID-19 11/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Esophageal Neoplasms (Esophageal Cancer) 12/2013
1	Stomach Neoplasms (Stomach Cancer) 12/2013
1	Carcinoma (Carcinomatosis) 04/2010
1	Disease Progression 04/2010
1	Prostatic Neoplasms (Prostate Cancer) 04/2010
1	Pharyngitis (Sore Throat) 03/2007
1	Carcinogenesis 10/2004

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2024 - 10/2004
5	Histocompatibility Antigens Class IIBA 01/2023 - 04/2010
4	MicroRNAs (MicroRNA)IBA 11/2022 - 01/2020
3	InterferonsIBA 01/2023 - 03/2007
3	AntigensIBA 11/2022 - 01/2017
2	Chemokine ReceptorsIBA 01/2024 - 01/2021
2	HLA Antigens (Human Leukocyte Antigens)IBA 08/2021 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 05/2021 - 08/2020
2	ChemokinesIBA 01/2021 - 11/2020
2	Member 2 Subfamily B ATP Binding Cassette TransporterIBA 08/2020 - 01/2020
2	Surface Antigens (Surface Antigen)IBA 08/2020 - 04/2010
2	Peptides (Polypeptides)IBA 01/2020 - 01/2019
2	HLA-A Antigens (HLA-A)IBA 01/2019 - 12/2013
1	protein kinase DIBA 01/2024
1	Protein Kinase CIBA 01/2024
1	LigandsIBA 12/2023
1	CXCR4 Receptors (CXCR4 Receptor)IBA 12/2023
1	SuspensionsIBA 12/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2023
1	Arginine (L-Arginine)FDA Link 01/2023
1	Leucine (L-Leucine)FDA Link 01/2023
1	Transforming Growth Factor-beta Type I ReceptorIBA 01/2023
1	purineIBA 01/2023
1	Protein Isoforms (Isoforms)IBA 01/2023
1	HLA-G Antigens (HLA G)IBA 11/2022
1	Histocompatibility Antigens Class IIIBA 08/2021
1	Everolimus FDA Link 05/2021
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2020
1	tapasinIBA 01/2020
1	transporter associated with antigen processing (TAP)IBA 01/2020
1	Formaldehyde (Formol)FDA Link 01/2020
1	Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA 01/2020
1	Horseradish PeroxidaseIBA 01/2020
1	LuciferasesIBA 01/2020
1	ParaffinIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Bovine Serum AlbuminIBA 01/2020
1	Untranslated Regions (Untranslated Region)IBA 01/2020
1	Firefly LuciferasesIBA 01/2020
1	AntibodiesIBA 10/2019
1	EpitopesIBA 01/2019
1	src-Family KinasesIBA 04/2016
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2016
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2013
1	Lapatinib (GW572016)FDA Link 12/2013
1	Small Interfering RNA (siRNA)IBA 12/2013
1	WortmanninIBA 12/2013
1	ErbB Receptors (EGF Receptor)IBA 12/2013
1	HLA-A24 AntigenIBA 12/2013
1	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 12/2013
1	CXC ChemokinesIBA 03/2007
1	Nuclear Proteins (Protein, Nuclear)IBA 10/2004

Therapy/Procedure

5	Immunotherapy 01/2023 - 04/2010
3	Therapeutics 05/2021 - 11/2016